This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
It is currently Tue May 21, 2013 6:37 pm

View unanswered posts | View active topics


Board index » Treatments » Copaxone

All times are UTC - 8 hours [ DST ]



Post new topic Reply to topic  Page 1 of 1
  [ 2 posts ] 
  Print view Previous topic | Next topic 
Author Message
scorpion
 Post subject: new formula
PostPosted: Sat Jun 05, 2010 6:23 pm 
Offline
Family Elder
User avatar

Joined: Wed Nov 05, 2008 4:00 pm
Posts: 1323
Teva announces positive results from a study assessing a new formulation of Copaxone.

<shortened url>
Top
 Profile  
 
DizzyDean
 Post subject:
PostPosted: Fri Jun 18, 2010 4:34 pm 
Offline
Family Member
User avatar

Joined: Fri Jun 01, 2007 3:00 pm
Posts: 45
The text seems to contradict the conclusion of the study - 12.5% vs 18.1% for those with the new formulation suggests a relative risk INCREASE of nearly 50% for tolerability problems with the new formulation.

A typo? Anybody have a link to the original paper?

Quote:
Adverse events were reported by 12.5 percent of patients when injecting 20mg/1.0mL and by 18.1 percent of patients when injecting 20mg/0.5mL.


Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  Page 1 of 1
  [ 2 posts ] 

Board index » Treatments » Copaxone

All times are UTC - 8 hours [ DST ]

Who is online

Users browsing this forum: No registered users

You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Search for:
Jump to: